Filtered By:
Source: Euro Surveill
Vaccination: Covid Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 329 results found since Jan 2013.
Can variants, reinfection, symptoms and test types affect COVID-19 diagnostic performance? A large-scale retrospective study of AG-RDTs during circulation of Delta and Omicron variants, Czechia, December 2021 to February 2022
ConclusionSensitivity for Omicron was lower in subgroups that may become more common if SARS-CoV-2 becomes an endemic virus.PMID:37733239 | DOI:10.2807/1560-7917.ES.2023.28.38.2200938
Source: Euro Surveill - September 21, 2023 Category: Infectious Diseases Authors: Tom áš Kliegr Ji ří Jarkovský Helena Ji řincová Jaroslav Kucha ř Tom áš Karel David Chud án Stanislav Voj íř Michal Zav řel Ond řej Šanca Ruth Tachezy Source Type: research
The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022
ConclusionEnhanced testing for respiratory viruses during the COVID-19 pandemic provided a more complete picture of influenza virus transmission compared with previous seasons. Returned international travellers were important drivers of influenza reemergence, as were young adults, a group whose role has previously been under-recognised in the establishment of seasonal influenza epidemics. Targeting interventions, including vaccination, to these groups could reduce future influenza transmission.PMID:37707981 | DOI:10.2807/1560-7917.ES.2023.28.37.2300118
Source: Euro Surveill - September 14, 2023 Category: Infectious Diseases Authors: Catherine Ga Pendrey Janet Strachan Heidi Peck Ammar Aziz Jean Moselen Rob Moss Md Rezanur Rahaman Ian G Barr Kanta Subbarao Sheena G Sullivan Source Type: research
A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022
In conclusion, this study demonstrates the feasibility of conducting variant severity analyses in a multinational collaborative framework and adds evidence for the reduced severity of the Omicron BA.1 variant.PMID:37676146 | PMC:PMC10486193 | DOI:10.2807/1560-7917.ES.2023.28.36.2300048
Source: Euro Surveill - September 7, 2023 Category: Infectious Diseases Authors: Tommy Nyberg Peter Bager Ingrid Bech Svalgaard Dritan Bejko Nick Bundle Josie Evans Tyra Grove Krause Jim McMenamin Jo ël Mossong Heather Mutch Ajibola Omokanye Andr é Peralta-Santos Pedro Pinto-Leite Jostein Starrfelt Simon Thelwall Lamprini Veneti Rob Source Type: research
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023
Euro Surveill. 2023 Aug;28(32). doi: 10.2807/1560-7917.ES.2023.28.32.2300397.ABSTRACTDuring predominant circulation of SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages (April-June 2023), we found that a second or third booster of Comirnaty bivalent Original/Omicron BA.4-5 mRNA vaccine, versus a first booster received at least 120 days earlier, was effective in preventing severe COVID-19 for more than 6 months post-administration in persons 60 years and above. In view of autumn 2023 vaccination campaigns, use of bivalent Original/Omicron BA.4-5 mRNA vaccines might be warranted until monovalent COVID-19 vaccines targetin...
Source: Euro Surveill - August 10, 2023 Category: Infectious Diseases Authors: Massimo Fabiani Alberto Mateo-Urdiales Chiara Sacco Maria Cristina Rota Emmanouil Alexandros Fotakis Daniele Petrone Martina Del Manso Andrea Siddu Paola Stefanelli Antonino Bella Flavia Riccardo Giovanni Rezza Anna Teresa Palamara Silvio Brusaferro Patri Source Type: research
